lactobionic acid has been researched along with Hepatocellular Carcinoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Du, K; Hu, H; Tao, Y; Xiao, W; Xu, D; Xu, Q; Yuan, X | 1 |
| Coelho, JFJ; Faneca, H; Mendonça, PV; Santo, D; Serra, AC | 1 |
| Arafa, K; El-Sherbiny, IM; Emara, M; Hefnawy, A; Khalil, IH | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, GQ | 1 |
| Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G | 1 |
| Fan, L; Guo, Y; Jiang, K; Li, B; Liu, Y; Shao, J; Shen, Z; Zhao, R; Zheng, G | 1 |
| Anwar, DM; Bekhit, AA; Elkhodairy, KA; Elzoghby, AO; Helmy, MW; Kamal, MK; Khattab, SN | 1 |
| Gao, X; Ji, Y; Jian, X; Li, Z; Liu, Z; Ni, W; Sun, S; Wu, L | 1 |
| Karmakar, P; Pal, K; Sahu, SK; Samui, A | 1 |
| Abdelmoneem, MA; Abdulkader, MA; Elkhodairy, KA; Elnaggar, MA; Elzoghby, AO; Fang, JY; Hammady, RS; Helmy, MW; Kamel, SM; Zaky, A | 1 |
| Agnihotri, A; Bansal, D; Dubey, N; Ganeshpurkar, A; Pandey, V; Yadav, K | 1 |
| Hassanzadeh, F; Khadem, M; Sadeghi, H; Varshosaz, J | 1 |
| Han, Y; Li, C; Li, Y; Yu, P; Zhang, X | 1 |
13 other study(ies) available for lactobionic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Indocyanine Green; Ligands; Liver Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2022 |
Targeted downregulation of MYC mediated by a highly efficient lactobionic acid-based glycoplex to enhance chemosensitivity in human hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; RNA, Small Interfering; Sorafenib | 2023 |
Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery.
Topics: Animals; Carcinoma, Hepatocellular; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Nanoparticles; Rats, Wistar | 2020 |
Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
Topics: Antibiotics, Antineoplastic; Bromelains; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Liver Neoplasms; Nanoparticles; Neoplasms | 2017 |
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid | 2017 |
A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Adhesion; Cell Proliferation; Dendrimers; Disaccharides; Drug Carriers; Drug Delivery Systems; Liver Neoplasms, Experimental; Matrix Metalloproteinase 9; Mice; Nanoparticles; Neoplasm Metastasis; Rats; Rats, Sprague-Dawley; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2018 |
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disaccharides; Drug Delivery Systems; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Micelles; Polysaccharides; Resveratrol; Sulfasalazine; Xenograft Model Antitumor Assays | 2018 |
Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biotin; Carcinoma, Hepatocellular; Curcumin; Disaccharides; Drug Carriers; Drug Liberation; Drug Synergism; Fluorouracil; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Polyglactin 910; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |
In situ synthesized lactobionic acid conjugated NMOFs, a smart material for imaging and targeted drug delivery in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Liver Neoplasms; Metal-Organic Frameworks | 2019 |
Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Disaccharides; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Ki-67 Antigen; Lactoferrin; Liver Neoplasms; Mice; Nanocapsules; NF-kappa B; Phytotherapy | 2019 |
Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Disaccharides; Drug Carriers; Drug Delivery Systems; Ethyldimethylaminopropyl Carbodiimide; Liposomes; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Oxaliplatin; Particle Size; Phosphatidylethanolamines; Tissue Distribution | 2016 |
Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Topics: Acetone; Amines; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Delayed-Action Preparations; Disaccharides; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Fluorouracil; Galactose; Glycerides; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanoparticles; Oleic Acid; Particle Size; Polysorbates; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2012 |
Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Topics: Antineoplastic Agents, Phytogenic; Asialoglycoprotein Receptor; beta-Cyclodextrins; Binding, Competitive; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disaccharides; Dose-Response Relationship, Drug; Drug Carriers; Drug Stability; Endocytosis; Feasibility Studies; Glycerol; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Micelles; Microscopy, Confocal; Molecular Structure; Nanoparticles; Paclitaxel; Polymers; Solubility; Technology, Pharmaceutical; Time Factors | 2013 |